Cardiac complications associated with HSCT

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter focuses on cardiotoxicity that may occur during the perior early post-HSCT period. The long-term cardiac sequelae associated with HSCT are addressed in Chap. 26. Cardiac complications may be related to the toxic effects of the conditioning regimen, radiation, prior exposure to cardiotoxic agents, infections, and graft-versus-host disease (GvHD). HSCT-associated cardiac complications include heart failure, arrhythmias, pericarditis, myocarditis, endocarditis, pericardial effusion, and cardiac tamponade. Cardiac complications may occur acutely during the peri-HSCT period (as defined as the time during conditioning through engraftment) or may be delayed by weeks to years. With the exception of sinus tachycardia, cardiac complications are rare during the peri-HSCT period. However, when they do occur, they are usually life-threatening because heart failure, cardiac tamponade, and dysrhythmias are the most common early cardiac complications. More frequently, the manifestations of the cardiac damage acquired during the peri-HSCT period may be delayed for years, requiring lifelong cardiac monitoring (at least annually with ECHO and ECG) for all post-HSCT patients who are at risk.

Original languageEnglish (US)
Title of host publicationHematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist
PublisherSpringer International Publishing
Pages333-341
Number of pages9
ISBN (Electronic)9783319631462
ISBN (Print)9783319631448
DOIs
StatePublished - Jan 1 2017

Fingerprint

Cardiac Tamponade
Cardiac Arrhythmias
Heart Failure
Cardiotoxins
Sinus Tachycardia
Pericarditis
Pericardial Effusion
Poisons
Myocarditis
Graft vs Host Disease
Endocarditis
Electrocardiography
Infection

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Brown, V. (2017). Cardiac complications associated with HSCT. In Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist (pp. 333-341). Springer International Publishing. https://doi.org/10.1007/978-3-319-63146-2_23
Brown, Valerie. / Cardiac complications associated with HSCT. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Springer International Publishing, 2017. pp. 333-341
@inbook{0e8320647da54d97acee2d413c5e035a,
title = "Cardiac complications associated with HSCT",
abstract = "This chapter focuses on cardiotoxicity that may occur during the perior early post-HSCT period. The long-term cardiac sequelae associated with HSCT are addressed in Chap. 26. Cardiac complications may be related to the toxic effects of the conditioning regimen, radiation, prior exposure to cardiotoxic agents, infections, and graft-versus-host disease (GvHD). HSCT-associated cardiac complications include heart failure, arrhythmias, pericarditis, myocarditis, endocarditis, pericardial effusion, and cardiac tamponade. Cardiac complications may occur acutely during the peri-HSCT period (as defined as the time during conditioning through engraftment) or may be delayed by weeks to years. With the exception of sinus tachycardia, cardiac complications are rare during the peri-HSCT period. However, when they do occur, they are usually life-threatening because heart failure, cardiac tamponade, and dysrhythmias are the most common early cardiac complications. More frequently, the manifestations of the cardiac damage acquired during the peri-HSCT period may be delayed for years, requiring lifelong cardiac monitoring (at least annually with ECHO and ECG) for all post-HSCT patients who are at risk.",
author = "Valerie Brown",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-3-319-63146-2_23",
language = "English (US)",
isbn = "9783319631448",
pages = "333--341",
booktitle = "Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist",
publisher = "Springer International Publishing",

}

Brown, V 2017, Cardiac complications associated with HSCT. in Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Springer International Publishing, pp. 333-341. https://doi.org/10.1007/978-3-319-63146-2_23

Cardiac complications associated with HSCT. / Brown, Valerie.

Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Springer International Publishing, 2017. p. 333-341.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Cardiac complications associated with HSCT

AU - Brown, Valerie

PY - 2017/1/1

Y1 - 2017/1/1

N2 - This chapter focuses on cardiotoxicity that may occur during the perior early post-HSCT period. The long-term cardiac sequelae associated with HSCT are addressed in Chap. 26. Cardiac complications may be related to the toxic effects of the conditioning regimen, radiation, prior exposure to cardiotoxic agents, infections, and graft-versus-host disease (GvHD). HSCT-associated cardiac complications include heart failure, arrhythmias, pericarditis, myocarditis, endocarditis, pericardial effusion, and cardiac tamponade. Cardiac complications may occur acutely during the peri-HSCT period (as defined as the time during conditioning through engraftment) or may be delayed by weeks to years. With the exception of sinus tachycardia, cardiac complications are rare during the peri-HSCT period. However, when they do occur, they are usually life-threatening because heart failure, cardiac tamponade, and dysrhythmias are the most common early cardiac complications. More frequently, the manifestations of the cardiac damage acquired during the peri-HSCT period may be delayed for years, requiring lifelong cardiac monitoring (at least annually with ECHO and ECG) for all post-HSCT patients who are at risk.

AB - This chapter focuses on cardiotoxicity that may occur during the perior early post-HSCT period. The long-term cardiac sequelae associated with HSCT are addressed in Chap. 26. Cardiac complications may be related to the toxic effects of the conditioning regimen, radiation, prior exposure to cardiotoxic agents, infections, and graft-versus-host disease (GvHD). HSCT-associated cardiac complications include heart failure, arrhythmias, pericarditis, myocarditis, endocarditis, pericardial effusion, and cardiac tamponade. Cardiac complications may occur acutely during the peri-HSCT period (as defined as the time during conditioning through engraftment) or may be delayed by weeks to years. With the exception of sinus tachycardia, cardiac complications are rare during the peri-HSCT period. However, when they do occur, they are usually life-threatening because heart failure, cardiac tamponade, and dysrhythmias are the most common early cardiac complications. More frequently, the manifestations of the cardiac damage acquired during the peri-HSCT period may be delayed for years, requiring lifelong cardiac monitoring (at least annually with ECHO and ECG) for all post-HSCT patients who are at risk.

UR - http://www.scopus.com/inward/record.url?scp=85043331907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043331907&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-63146-2_23

DO - 10.1007/978-3-319-63146-2_23

M3 - Chapter

AN - SCOPUS:85043331907

SN - 9783319631448

SP - 333

EP - 341

BT - Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist

PB - Springer International Publishing

ER -

Brown V. Cardiac complications associated with HSCT. In Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Springer International Publishing. 2017. p. 333-341 https://doi.org/10.1007/978-3-319-63146-2_23